These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 25302468)

  • 1. Basal cell carcinoma, Hedgehog signaling, and targeted therapeutics: the long and winding road.
    Wong SY; Dlugosz AA
    J Invest Dermatol; 2014 Oct; 134(e1):E18-22. PubMed ID: 25302468
    [No Abstract]   [Full Text] [Related]  

  • 2. [Targeted therapy of basal cell carcinoma through inhibition of the hedgehog signaling pathway].
    Hafner C
    Hautarzt; 2010 Apr; 61(4):356-8. PubMed ID: 20309511
    [No Abstract]   [Full Text] [Related]  

  • 3. Basal cell carcinoma - molecular biology and potential new therapies.
    Kasper M; Jaks V; Hohl D; Toftgård R
    J Clin Invest; 2012 Feb; 122(2):455-63. PubMed ID: 22293184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basal cell carcinoma: hedgehog pathway inhibitors and beyond.
    Walls B
    Cutis; 2013 Jun; 91(6):E1-4. PubMed ID: 23837158
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical experience with Hedgehog pathway inhibitors.
    Low JA; de Sauvage FJ
    J Clin Oncol; 2010 Dec; 28(36):5321-6. PubMed ID: 21041712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harnessing hedgehog for the treatment of basal cell carcinoma.
    Harms KL; Dlugosz AA
    JAMA Dermatol; 2013 May; 149(5):607-8. PubMed ID: 23677088
    [No Abstract]   [Full Text] [Related]  

  • 7. Locally advanced and metastatic basal cell carcinoma: molecular pathways, treatment options and new targeted therapies.
    Ruiz Salas V; Alegre M; Garcés JR; Puig L
    Expert Rev Anticancer Ther; 2014 Jun; 14(6):741-9. PubMed ID: 24611655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced basal cell carcinoma of the skin: targeting the hedgehog pathway.
    Sekulic A; Mangold AR; Northfelt DW; LoRusso PM
    Curr Opin Oncol; 2013 May; 25(3):218-23. PubMed ID: 23493193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in the treatment of Basal cell carcinoma: Hedgehog inhibitors.
    Kudchadkar R; Lewis K; Gonzalez R
    Semin Oncol; 2012 Apr; 39(2):139-44. PubMed ID: 22484185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precision medicine and precision therapeutics: hedgehog signaling pathway, basal cell carcinoma and beyond.
    Mohan SV; Chang AL
    Semin Cutan Med Surg; 2014 Jun; 33(2):68-71. PubMed ID: 25085664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sonic Hedgehog signaling pathway: from embryology to molecular targeted therapies].
    Watson S; Serrate C; Vignot S
    Bull Cancer; 2010 Dec; 97(12):1477-83. PubMed ID: 21220225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral hedgehog-pathway inhibitors for basal-cell carcinoma.
    Lear JT
    N Engl J Med; 2012 Jun; 366(23):2225-6. PubMed ID: 22670909
    [No Abstract]   [Full Text] [Related]  

  • 13. Hedgehog Pathway Inhibition for the Treatment of Basal Cell Carcinoma.
    Gutzmer R; Solomon JA
    Target Oncol; 2019 Jun; 14(3):253-267. PubMed ID: 31243642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary cilia can both mediate and suppress Hedgehog pathway-dependent tumorigenesis.
    Wong SY; Seol AD; So PL; Ermilov AN; Bichakjian CK; Epstein EH; Dlugosz AA; Reiter JF
    Nat Med; 2009 Sep; 15(9):1055-61. PubMed ID: 19701205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein kinase A activation inhibits oncogenic Sonic hedgehog signalling and suppresses basal cell carcinoma of the skin.
    Makinodan E; Marneros AG
    Exp Dermatol; 2012 Nov; 21(11):847-52. PubMed ID: 23163650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hedgehog signalling in skin development and cancer.
    Athar M; Tang X; Lee JL; Kopelovich L; Kim AL
    Exp Dermatol; 2006 Sep; 15(9):667-77. PubMed ID: 16881963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the adverse events related to hedgehog pathway inhibitor therapy for basal cell carcinoma: A single-centre retrospective study.
    Villani A; Fabbrocini G; Costa C; Cappello M; Scalvenzi M
    Australas J Dermatol; 2021 May; 62(2):e296-e297. PubMed ID: 33040336
    [No Abstract]   [Full Text] [Related]  

  • 18. Sonic Hedgehog pathway inhibitors: from clinical trials to clinical practice.
    Yan BY; Hibler BP; Menge T; Dunn L; Ho AL; Rossi AM
    Br J Dermatol; 2019 May; 180(5):1260-1261. PubMed ID: 30693471
    [No Abstract]   [Full Text] [Related]  

  • 19. Companies race to develop first Hedgehog inhibitor cancer drug.
    Dolgin E
    Nat Med; 2011 May; 17(5):523. PubMed ID: 21546955
    [No Abstract]   [Full Text] [Related]  

  • 20. Hedgehog- and mTOR-targeted therapies for advanced basal cell carcinomas.
    Piérard-Franchimont C; Hermanns-Lê T; Paquet P; Herfs M; Delvenne P; Piérard GE
    Future Oncol; 2015 Nov; 11(22):2997-3002. PubMed ID: 26437034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.